Company

Our
Company

We are more than a radioisotope supplier. We are solving the challenges facing U.S. radioisotope customers and constantly evolving to meet changing needs.

IN OUR EFFORTS TO DELIVER
CREATIVE SOLUTIONS, WE
CLEARLY DEFINE

WHO
WE ARE

We are innovators who revolutionized the reliable production of Mo-99. We are dedicated to preserving the environment using non-uranium production methods. We are pioneers working with industry leaders to develop and commercialize new diagnostics and therapeutics that will serve the next generation of medical advances for patients.

THE RADIOPHARMACEUTICAL MARKET
DEMANDS CREATIVE, ORIGINAL
THINKING, LIKE THAT PIONEERED BY OUR

LEADERSHIP
TEAM

Our executive team brings proven experience and expertise in developing and commercializing innovative nuclear medicine products and technologies.

LATEST NEWS, PRESS RELEASES & EVENTS


News - Mar 30, 2022
NorthStar and its Future with Electron Accelerator Technology

Press Releases - Mar 29, 2022
NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones

Press Releases - Mar 9, 2022
NorthStar Medical Radioisotopes and Convergent Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)
Oct 22, 2022 - Oct 23, 2022
Meeting
Central Chapter of Society of Nuclear Medicine and Molecular Imaging (CCSNMMI) 2022 Fall Education Symposium
Exhibiting